Medicare Enrolled

Dr. Analisa Arosemena, MD

Ophthalmology · Miami Beach, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
7135 COLLINS AVE APT 1233, Miami Beach, FL 33141
7863757433
Registered in NPPES since 2006
NPI: 1346346491 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Arosemena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arosemena? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Arosemena

Dr. Analisa Arosemena is an ophthalmology specialist in Miami Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Arosemena performed 240 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Arosemena received a total of $318,839 from 36 pharmaceutical and/or device companies across 788 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Arosemena is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 240 Medicare services $318,839 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
240
Medicare services
Bottom 9% in FL for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
61 $84 $165
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
59 $29 $75
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
55 $64 $150
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
40 $28 $75
Ultrasound scan to determine eye length and lens power
An ultrasound procedure used to measure the length of the eye and calculate the power of the lens.
14 $30 $125
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
11 $378 $2,500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.6% high complexity
22.5% medium
72.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$318,839
Total received (2018-2024)
Avg $45,548/year across 7 years
Top 2% in FL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
788
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$121,928
2023
$49,143
2022
$59,550
2021
$37,537
2020
$14,627
2019
$32,468
2018
$3,585

Payments by company (2024)

Alcon Vision LLC
$40,701
ABBVIE INC.
$39,292
Glaukos Corporation
$16,118
NEW WORLD MEDICAL,INC.
$15,697
Nova Eye, Inc.
$4,972
Harrow Eye, LLC
$2,211
Carl Zeiss Meditec USA, Inc.
$1,408
SUN PHARMACEUTICAL INDUSTRIES INC.
$368
Bausch & Lomb Americas Inc.
$339
Tarsus Pharmaceuticals, Inc.
$159
RxSight Inc
$148
Sight Sciences, Inc.
$131
Amgen Inc.
$122
Oculus Surgical Inc.
$78
Thea Pharma Inc.
$48
BIOTISSUE HOLDINGS INC.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$36
Mallinckrodt Hospital Products Inc.
$34
Dompe US, Inc.
$29
Top 3 companies account for 78.8% of 2024 payments
All-time payments by company (2018-2024) ›
Alcon Vision LLC
$63,506
ABBVIE INC.
$60,815
Aerie Pharmaceuticals, Inc.
$33,415
Allergan, Inc.
$26,931
Allergan Inc.
$25,882
AbbVie Inc.
$23,279
NEW WORLD MEDICAL,INC.
$21,056
Glaukos Corporation
$16,397
Nova Eye, Inc.
$15,130
Sight Sciences, Inc.
$11,043
Iridex Corporation
$8,610
Ivantis, Inc
$2,670
Harrow Eye, LLC
$2,211
Johnson & Johnson Surgical Vision, Inc.
$1,461
Carl Zeiss Meditec USA, Inc.
$1,408
Sun Pharmaceutical Industries Inc.
$859
SUN PHARMACEUTICAL INDUSTRIES INC.
$702
Oculus Surgical Inc.
$654
Bausch & Lomb Americas Inc.
$521
Thea Pharma Inc.
$472
Dompe US, Inc.
$434
RxSight Inc
$351
Mallinckrodt Hospital Products Inc.
$176
Tarsus Pharmaceuticals, Inc.
$159
Amgen Inc.
$122
Bausch & Lomb, a division of Bausch Health US, LLC
$102
Ocular Therapeutix, Inc.
$85
Oyster Point Pharma, Inc.
$77
Novartis Pharmaceuticals Corporation
$77
EYEVANCE PHARMACEUTICALS LLC
$76
BIOTISSUE HOLDINGS INC.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$36
Alcon Laboratories Inc
$34
Carl Zeiss Meditec, Inc.
$17
TISSUETECH, INC.
$17
Shire North American Group Inc
$16
Top 3 companies account for 49.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · ARGOS · AcrySof IQ PanOptix · Ahmed Glaucoma Valve · BROMSITE · CE-marked KXLA system · CIRRUS HD-OCT · COMBIGAN · Cequa · Clareon · CyPass · DEXTENZA · DUREZOL · DURYSTA · GONIO ready · HYDRUS Microstent · Hydrus · Hydrus Microstent · INFUSE · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · Kahook Dual Blade · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LIVTENCITY · LOTEMAX SM · LUMIGAN · LenSx · MIEBO · None Specified · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · PROKERA · PanOptix · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · Radius · Rhopressa · Rocklatan · SION SURGICAL INSTRUMENT · Simbrinza · Streamline · TECNIS IOL · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis 1-piece IOL · Tecnis 3-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · VEVYE · VUITY · VYZULTA · XDEMVY · XELPROS · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · iDose · iStent Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · rhopressa · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Miami Beach?
Compare ophthalmologists in the Miami Beach area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
374
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
2.4 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Arosemena is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Arosemena experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Arosemena performed 61 comprehensive eye exam, established patient services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Arosemena receive payments from pharmaceutical companies?
Yes. Dr. Arosemena received a total of $318,839 from 36 companies across 788 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arosemena's costs compare to other ophthalmologists in Miami Beach?
Dr. Arosemena's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arosemena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →